{"entity":{"type":"insider","cik":"0001512127","url":"/insider/0001512127","json_url":"/insider/0001512127.json","name":"BESSER JAMES E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":265,"n_filings":36,"first":"2017-08-01","last":"2025-12-15","span_basis":"filed_date"},"name_variants":[{"name":"BESSER JAMES E","source":"filing","n_filings":36,"first_seen":"2017-08-01","last_seen":"2025-12-15"}],"transactions":[{"id":4295175,"accession":"0000919574-25-007394","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-007394","line_url":"/filing/0000919574-25-007394#line-2","is_derivative":false,"issuer_cik":"0001169253","issuer_name":"SANUWAVE Health, Inc.","issuer_ticker":"SNWV","issuer_name_source":null,"issuer_url":"/issuer/0001169253","owner_cik":null,"owner_name":"Manchester Explorer, L.P.; MANCHESTER MANAGEMENT PR, LLC; MANCHESTER MANAGEMENT CO LLC; FRANK MORGAN C.; BESSER JAMES E","owner_display_name":"Manchester Explorer, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":21.0444,"price_display":"21.04","price_state":"stated","total_value":136788.6,"total_display":"136,788.60","total_whole":"136,789","shares_owned_after":63999.0,"shares_owned_after_display":"63,999","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-12","filed_date":"2025-12-15","scope":"insider"},{"id":4295171,"accession":"0000919574-25-007394","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-007394","line_url":"/filing/0000919574-25-007394#line-1","is_derivative":false,"issuer_cik":"0001169253","issuer_name":"SANUWAVE Health, Inc.","issuer_ticker":"SNWV","issuer_name_source":null,"issuer_url":"/issuer/0001169253","owner_cik":null,"owner_name":"Manchester Explorer, L.P.; MANCHESTER MANAGEMENT PR, LLC; MANCHESTER MANAGEMENT CO LLC; FRANK MORGAN C.; BESSER JAMES E","owner_display_name":"Manchester Explorer, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13500.0,"shares_display":"13,500","price_per_share":31.2798,"price_display":"31.28","price_state":"stated","total_value":422277.3,"total_display":"422,277.30","total_whole":"422,277","shares_owned_after":70499.0,"shares_owned_after_display":"70,499","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-11","filed_date":"2025-12-15","scope":"insider"},{"id":9208506,"accession":"0000919574-25-007331","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-007331","line_url":"/filing/0000919574-25-007331#line-3","is_derivative":false,"issuer_cik":"0001169253","issuer_name":"SANUWAVE Health, Inc.","issuer_ticker":"SNWV","issuer_name_source":null,"issuer_url":"/issuer/0001169253","owner_cik":null,"owner_name":"BESSER JAMES E; FRANK MORGAN C.; MANCHESTER MANAGEMENT CO LLC; MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.","owner_display_name":"BESSER JAMES E","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8625.0,"shares_display":"8,625","price_per_share":30.3918,"price_display":"30.39","price_state":"stated","total_value":262129.275,"total_display":"262,129.28","total_whole":"262,129","shares_owned_after":863980.0,"shares_owned_after_display":"863,980","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-10","filed_date":"2025-12-11","scope":"insider"},{"id":4162335,"accession":"0000919574-25-007315","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-25-007315","line_url":"/filing/0000919574-25-007315#line-4","is_derivative":false,"issuer_cik":"0001169253","issuer_name":"SANUWAVE Health, Inc.","issuer_ticker":"SNWV","issuer_name_source":null,"issuer_url":"/issuer/0001169253","owner_cik":null,"owner_name":"MANCHESTER MANAGEMENT CO LLC; MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.; FRANK MORGAN C.; BESSER JAMES E","owner_display_name":"MANCHESTER MANAGEMENT CO LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8625.0,"shares_display":"8,625","price_per_share":30.3918,"price_display":"30.39","price_state":"stated","total_value":262129.275,"total_display":"262,129.28","total_whole":"262,129","shares_owned_after":863980.0,"shares_owned_after_display":"863,980","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-10","filed_date":"2025-12-10","scope":"insider"},{"id":9208503,"accession":"0000919574-25-007331","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-007331","line_url":"/filing/0000919574-25-007331#line-2","is_derivative":false,"issuer_cik":"0001169253","issuer_name":"SANUWAVE Health, Inc.","issuer_ticker":"SNWV","issuer_name_source":null,"issuer_url":"/issuer/0001169253","owner_cik":null,"owner_name":"BESSER JAMES E; FRANK MORGAN C.; MANCHESTER MANAGEMENT CO LLC; MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.","owner_display_name":"BESSER JAMES E","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8785.0,"shares_display":"8,785","price_per_share":30.5838,"price_display":"30.58","price_state":"stated","total_value":268678.683,"total_display":"268,678.68","total_whole":"268,679","shares_owned_after":872605.0,"shares_owned_after_display":"872,605","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-11","scope":"insider"},{"id":4162331,"accession":"0000919574-25-007315","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-007315","line_url":"/filing/0000919574-25-007315#line-3","is_derivative":false,"issuer_cik":"0001169253","issuer_name":"SANUWAVE Health, Inc.","issuer_ticker":"SNWV","issuer_name_source":null,"issuer_url":"/issuer/0001169253","owner_cik":null,"owner_name":"MANCHESTER MANAGEMENT CO LLC; MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.; FRANK MORGAN C.; BESSER JAMES E","owner_display_name":"MANCHESTER MANAGEMENT CO LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8785.0,"shares_display":"8,785","price_per_share":30.5838,"price_display":"30.58","price_state":"stated","total_value":268678.683,"total_display":"268,678.68","total_whole":"268,679","shares_owned_after":872605.0,"shares_owned_after_display":"872,605","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-10","scope":"insider"},{"id":9208505,"accession":"0000919574-25-007331","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-25-007331","line_url":"/filing/0000919574-25-007331","is_derivative":false,"issuer_cik":"0001169253","issuer_name":"SANUWAVE Health, Inc.","issuer_ticker":"SNWV","issuer_name_source":null,"issuer_url":"/issuer/0001169253","owner_cik":null,"owner_name":"BESSER JAMES E; FRANK MORGAN C.; MANCHESTER MANAGEMENT CO LLC; MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.","owner_display_name":"BESSER JAMES E","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":127400.0,"shares_display":"127,400","price_per_share":30.7633704866562,"price_display":"30.76","price_state":"stated","total_value":3919253.4,"total_display":"3,919,253.40","total_whole":"3,919,253","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-11","scope":"insider","n_lines":2},{"id":4162326,"accession":"0000919574-25-007315","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-007315","line_url":"/filing/0000919574-25-007315","is_derivative":false,"issuer_cik":"0001169253","issuer_name":"SANUWAVE Health, Inc.","issuer_ticker":"SNWV","issuer_name_source":null,"issuer_url":"/issuer/0001169253","owner_cik":null,"owner_name":"MANCHESTER MANAGEMENT CO LLC; MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.; FRANK MORGAN C.; BESSER JAMES E","owner_display_name":"MANCHESTER MANAGEMENT CO LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":127400.0,"shares_display":"127,400","price_per_share":30.7633704866562,"price_display":"30.76","price_state":"stated","total_value":3919253.4,"total_display":"3,919,253.40","total_whole":"3,919,253","shares_owned_after":881390.0,"shares_owned_after_display":"881,390","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider","n_lines":2},{"id":4747226,"accession":"0000919574-25-002089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-002089","line_url":"/filing/0000919574-25-002089","is_derivative":false,"issuer_cik":"0001074871","issuer_name":"Modular Medical, Inc.","issuer_ticker":"MODD","issuer_name_source":null,"issuer_url":"/issuer/0001074871","owner_cik":null,"owner_name":"MANCHESTER MANAGEMENT CO LLC; Manchester Explorer, L.P.; MANCHESTER MANAGEMENT PR, LLC; FRANK MORGAN C.; BESSER JAMES E; JEB Partners, L.P.","owner_display_name":"MANCHESTER MANAGEMENT CO LLC","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":677082.0,"shares_display":"677,082","price_per_share":1.92,"price_display":"1.92","price_state":"stated","total_value":1299997.44,"total_display":"1,299,997.44","total_whole":"1,299,997","shares_owned_after":3805575.0,"shares_owned_after_display":"3,805,575","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-24","scope":"insider","n_lines":2},{"id":2300374,"accession":"0000919574-24-007009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-007009","line_url":"/filing/0000919574-24-007009#line-1","is_derivative":false,"issuer_cik":"0001074871","issuer_name":"Modular Medical, Inc.","issuer_ticker":"MODD","issuer_name_source":null,"issuer_url":"/issuer/0001074871","owner_cik":null,"owner_name":"JEB Partners, L.P.; MANCHESTER MANAGEMENT CO LLC; FRANK MORGAN C.; BESSER JAMES E; MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.","owner_display_name":"JEB Partners, L.P.","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21000.0,"shares_display":"21,000","price_per_share":1.6779,"price_display":"1.68","price_state":"stated","total_value":35235.9,"total_display":"35,235.90","total_whole":"35,236","shares_owned_after":265750.0,"shares_owned_after_display":"265,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-03","filed_date":"2024-12-04","scope":"insider"},{"id":2338777,"accession":"0000919574-24-006936","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-006936","line_url":"/filing/0000919574-24-006936#line-1","is_derivative":false,"issuer_cik":"0001074871","issuer_name":"Modular Medical, Inc.","issuer_ticker":"MODD","issuer_name_source":null,"issuer_url":"/issuer/0001074871","owner_cik":null,"owner_name":"Manchester Explorer, L.P.; MANCHESTER MANAGEMENT PR, LLC; MANCHESTER MANAGEMENT CO LLC; FRANK MORGAN C.; JEB Partners, L.P.; BESSER JAMES E","owner_display_name":"Manchester Explorer, L.P.","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.6895,"price_display":"1.69","price_state":"stated","total_value":168950.0,"total_display":"168,950.00","total_whole":"168,950","shares_owned_after":244750.0,"shares_owned_after_display":"244,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-27","filed_date":"2024-11-29","scope":"insider"},{"id":2537049,"accession":"0000919574-24-006890","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-006890","line_url":"/filing/0000919574-24-006890#line-1","is_derivative":false,"issuer_cik":"0001074871","issuer_name":"Modular Medical, Inc.","issuer_ticker":"MODD","issuer_name_source":null,"issuer_url":"/issuer/0001074871","owner_cik":null,"owner_name":"MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.; MANCHESTER MANAGEMENT CO LLC; BESSER JAMES E; JEB Partners, L.P.","owner_display_name":"MANCHESTER MANAGEMENT PR, LLC","owner_url":null,"role":"Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":166666.0,"shares_display":"166,666","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":249999.0,"total_display":"249,999.00","total_whole":"249,999","shares_owned_after":3284743.0,"shares_owned_after_display":"3,284,743","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-21","filed_date":"2024-11-25","scope":"insider"},{"id":2765277,"accession":"0000919574-24-005981","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0000919574-24-005981","line_url":"/filing/0000919574-24-005981#line-18","is_derivative":false,"issuer_cik":"0001169253","issuer_name":"SANUWAVE Health, Inc.","issuer_ticker":"SNWV","issuer_name_source":null,"issuer_url":"/issuer/0001169253","owner_cik":null,"owner_name":"MANCHESTER MANAGEMENT PR, LLC; BESSER JAMES E; MANCHESTER MANAGEMENT CO LLC; Manchester Explorer, L.P.; FRANK MORGAN C.","owner_display_name":"MANCHESTER MANAGEMENT PR, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":181818.0,"shares_display":"181,818","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":1499998.5,"total_display":"1,499,998.50","total_whole":"1,499,999","shares_owned_after":1006790.0,"shares_owned_after_display":"1,006,790","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-23","scope":"insider"},{"id":9208497,"accession":"0000919574-24-006889","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-006889","line_url":"/filing/0000919574-24-006889#line-1","is_derivative":false,"issuer_cik":"0001735534","issuer_name":"Modular Medical, Inc.","issuer_ticker":"MODD","issuer_name_source":null,"issuer_url":"/issuer/0001735534","owner_cik":null,"owner_name":"BESSER JAMES E; MANCHESTER MANAGEMENT CO LLC; MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.","owner_display_name":"BESSER JAMES E","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900000.0,"shares_display":"900,000","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":990000.0,"total_display":"990,000.00","total_whole":"990,000","shares_owned_after":3118077.0,"shares_owned_after_display":"3,118,077","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-11-25","scope":"insider"},{"id":2579669,"accession":"0000919574-24-001612","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-001612","line_url":"/filing/0000919574-24-001612#line-1","is_derivative":false,"issuer_cik":"0001074871","issuer_name":"Modular Medical, Inc.","issuer_ticker":"MODD","issuer_name_source":null,"issuer_url":"/issuer/0001074871","owner_cik":null,"owner_name":"BESSER JAMES E; JEB Partners, L.P.; MANCHESTER MANAGEMENT CO LLC; Manchester Explorer, L.P.; MANCHESTER MANAGEMENT PR, LLC","owner_display_name":"BESSER JAMES E","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900000.0,"shares_display":"900,000","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":990000.0,"total_display":"990,000.00","total_whole":"990,000","shares_owned_after":3118227.0,"shares_owned_after_display":"3,118,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-21","scope":"insider"},{"id":8213649,"accession":"0000919574-23-005719","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-23-005719","line_url":"/filing/0000919574-23-005719","is_derivative":false,"issuer_cik":"0001074871","issuer_name":"Modular Medical, Inc.","issuer_ticker":"MODD","issuer_name_source":null,"issuer_url":"/issuer/0001074871","owner_cik":null,"owner_name":"JEB Partners, L.P.; MANCHESTER MANAGEMENT CO LLC; MANCHESTER MANAGEMENT PR, LLC; BESSER JAMES E","owner_display_name":"JEB Partners, L.P.","owner_url":null,"role":"Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33000.0,"shares_display":"33,000","price_per_share":1.0764424242424242,"price_display":"1.08","price_state":"stated","total_value":35522.6,"total_display":"35,522.60","total_whole":"35,523","shares_owned_after":144750.0,"shares_owned_after_display":"144,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-18","scope":"insider","n_lines":2},{"id":6982028,"accession":"0000919574-22-001656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-22-001656","line_url":"/filing/0000919574-22-001656#line-1","is_derivative":false,"issuer_cik":"0001074871","issuer_name":"Modular Medical, Inc.","issuer_ticker":"MODD","issuer_name_source":null,"issuer_url":"/issuer/0001074871","owner_cik":null,"owner_name":"FRANK MORGAN C.; MANCHESTER MANAGEMENT PR, LLC; MANCHESTER MANAGEMENT CO LLC; BESSER JAMES E; Manchester Explorer, L.P.","owner_display_name":"FRANK MORGAN C.","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":1800000.0,"total_display":"1,800,000.00","total_whole":"1,800,000","shares_owned_after":1983803.0,"shares_owned_after_display":"1,983,803","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-10","filed_date":"2022-02-14","scope":"insider"},{"id":9208435,"accession":"0000919574-21-003218","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-21-003218","line_url":"/filing/0000919574-21-003218#line-3","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":10.76,"price_display":"10.76","price_state":"stated","total_value":4304000.0,"total_display":"4,304,000.00","total_whole":"4,304,000","shares_owned_after":648300.0,"shares_owned_after_display":"648,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-08","filed_date":"2021-05-05","scope":"insider"},{"id":5238974,"accession":"0000919574-21-002824","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-21-002824","line_url":"/filing/0000919574-21-002824#line-3","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":10.76,"price_display":"10.76","price_state":"stated","total_value":4304000.0,"total_display":"4,304,000.00","total_whole":"4,304,000","shares_owned_after":648300.0,"shares_owned_after_display":"648,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-08","filed_date":"2021-04-08","scope":"insider"},{"id":9208434,"accession":"0000919574-21-003218","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-21-003218","line_url":"/filing/0000919574-21-003218#line-2","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":10.67,"price_display":"10.67","price_state":"stated","total_value":170720.0,"total_display":"170,720.00","total_whole":"170,720","shares_owned_after":1048300.0,"shares_owned_after_display":"1,048,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-07","filed_date":"2021-05-05","scope":"insider"},{"id":5238971,"accession":"0000919574-21-002824","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-21-002824","line_url":"/filing/0000919574-21-002824#line-2","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":10.67,"price_display":"10.67","price_state":"stated","total_value":170720.0,"total_display":"170,720.00","total_whole":"170,720","shares_owned_after":1048300.0,"shares_owned_after_display":"1,048,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-07","filed_date":"2021-04-08","scope":"insider"},{"id":9208433,"accession":"0000919574-21-003218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-21-003218","line_url":"/filing/0000919574-21-003218#line-1","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31771.0,"shares_display":"31,771","price_per_share":10.91,"price_display":"10.91","price_state":"stated","total_value":346621.61,"total_display":"346,621.61","total_whole":"346,622","shares_owned_after":1064300.0,"shares_owned_after_display":"1,064,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-06","filed_date":"2021-05-05","scope":"insider"},{"id":5238967,"accession":"0000919574-21-002824","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-21-002824","line_url":"/filing/0000919574-21-002824#line-1","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31771.0,"shares_display":"31,771","price_per_share":10.91,"price_display":"10.91","price_state":"stated","total_value":346621.61,"total_display":"346,621.61","total_whole":"346,622","shares_owned_after":1064300.0,"shares_owned_after_display":"1,064,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-06","filed_date":"2021-04-08","scope":"insider"},{"id":9208431,"accession":"0000919574-21-003214","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-21-003214","line_url":"/filing/0000919574-21-003214#line-3","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20929.0,"shares_display":"20,929","price_per_share":11.56,"price_display":"11.56","price_state":"stated","total_value":241939.24,"total_display":"241,939.24","total_whole":"241,939","shares_owned_after":1096071.0,"shares_owned_after_display":"1,096,071","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-22","filed_date":"2021-05-05","scope":"insider"},{"id":4165046,"accession":"0000919574-21-001888","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-21-001888","line_url":"/filing/0000919574-21-001888#line-3","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20929.0,"shares_display":"20,929","price_per_share":11.56,"price_display":"11.56","price_state":"stated","total_value":241939.24,"total_display":"241,939.24","total_whole":"241,939","shares_owned_after":1096071.0,"shares_owned_after_display":"1,096,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-22","filed_date":"2021-02-22","scope":"insider"},{"id":9208432,"accession":"0000919574-21-003214","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-21-003214","line_url":"/filing/0000919574-21-003214#line-2","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.2,"price_display":"11.20","price_state":"stated","total_value":33600.0,"total_display":"33,600.00","total_whole":"33,600","shares_owned_after":1117000.0,"shares_owned_after_display":"1,117,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-05-05","scope":"insider"},{"id":4165040,"accession":"0000919574-21-001888","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-21-001888","line_url":"/filing/0000919574-21-001888#line-2","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.2,"price_display":"11.20","price_state":"stated","total_value":33600.0,"total_display":"33,600.00","total_whole":"33,600","shares_owned_after":1117000.0,"shares_owned_after_display":"1,117,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-02-22","scope":"insider"},{"id":9208430,"accession":"0000919574-21-003214","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-21-003214","line_url":"/filing/0000919574-21-003214#line-1","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":11.35,"price_display":"11.35","price_state":"stated","total_value":56750.0,"total_display":"56,750.00","total_whole":"56,750","shares_owned_after":1120000.0,"shares_owned_after_display":"1,120,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-05-05","scope":"insider"},{"id":4165033,"accession":"0000919574-21-001888","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-21-001888","line_url":"/filing/0000919574-21-001888#line-1","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":11.35,"price_display":"11.35","price_state":"stated","total_value":56750.0,"total_display":"56,750.00","total_whole":"56,750","shares_owned_after":1120000.0,"shares_owned_after_display":"1,120,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-02-22","scope":"insider"},{"id":4407119,"accession":"0000919574-21-006530","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-21-006530","line_url":"/filing/0000919574-21-006530#line-3","is_derivative":false,"issuer_cik":"0001074871","issuer_name":"Modular Medical, Inc.","issuer_ticker":"MODD","issuer_name_source":null,"issuer_url":"/issuer/0001074871","owner_cik":null,"owner_name":"MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.; FRANK MORGAN C.; BESSER JAMES E; MANCHESTER MANAGEMENT CO LLC","owner_display_name":"MANCHESTER MANAGEMENT PR, LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34843.0,"shares_display":"34,843","price_per_share":2.87,"price_display":"2.87","price_state":"stated","total_value":99999.41,"total_display":"99,999.41","total_whole":"99,999","shares_owned_after":304562.0,"shares_owned_after_display":"304,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-30","filed_date":"2021-10-29","scope":"insider"},{"id":2514539,"accession":"0000919574-20-006339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-20-006339","line_url":"/filing/0000919574-20-006339#line-1","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":4.04,"price_display":"4.04","price_state":"stated","total_value":121200.0,"total_display":"121,200.00","total_whole":"121,200","shares_owned_after":405000.0,"shares_owned_after_display":"405,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-02","filed_date":"2020-10-13","scope":"insider"},{"id":2289250,"accession":"0000919574-20-004833","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-20-004833","line_url":"/filing/0000919574-20-004833","is_derivative":false,"issuer_cik":"0001169253","issuer_name":"Zoom Telephonics, Inc.","issuer_ticker":"ZMTP","issuer_name_source":null,"issuer_url":"/issuer/0001169253","owner_cik":null,"owner_name":"BESSER JAMES E; Manchester Explorer, L.P.; FRANK MORGAN C.; MANCHESTER MANAGEMENT CO LLC","owner_display_name":"BESSER JAMES E","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7431071.0,"shares_display":"7,431,071","price_per_share":1.95,"price_display":"1.95","price_state":"stated","total_value":14490588.45,"total_display":"14,490,588.45","total_whole":"14,490,588","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider","n_lines":4},{"id":4407117,"accession":"0000919574-21-006530","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-21-006530","line_url":"/filing/0000919574-21-006530","is_derivative":false,"issuer_cik":"0001074871","issuer_name":"Modular Medical, Inc.","issuer_ticker":"MODD","issuer_name_source":null,"issuer_url":"/issuer/0001074871","owner_cik":null,"owner_name":"MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.; FRANK MORGAN C.; BESSER JAMES E; MANCHESTER MANAGEMENT CO LLC","owner_display_name":"MANCHESTER MANAGEMENT PR, LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":139372.0,"shares_display":"139,372","price_per_share":2.87,"price_display":"2.87","price_state":"stated","total_value":399997.64,"total_display":"399,997.64","total_whole":"399,998","shares_owned_after":1022105.0,"shares_owned_after_display":"1,022,105","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-30","filed_date":"2021-10-29","scope":"insider","n_lines":2},{"id":7808820,"accession":"0000919574-19-006192","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-19-006192","line_url":"/filing/0000919574-19-006192#line-1","is_derivative":false,"issuer_cik":"0001022505","issuer_name":"CIPHERLOC Corp","issuer_ticker":"CLOK","issuer_name_source":null,"issuer_url":"/issuer/0001022505","owner_cik":null,"owner_name":"BESSER JAMES E; MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.; MANCHESTER MANAGEMENT CO LLC","owner_display_name":"BESSER JAMES E","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10600.0,"shares_display":"10,600","price_per_share":0.54,"price_display":"0.54","price_state":"stated","total_value":5724.0,"total_display":"5,724.00","total_whole":"5,724","shares_owned_after":4261000.0,"shares_owned_after_display":"4,261,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-30","filed_date":"2019-10-03","scope":"insider"},{"id":7858818,"accession":"0000919574-19-006090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-19-006090","line_url":"/filing/0000919574-19-006090#line-2","is_derivative":false,"issuer_cik":"0001022505","issuer_name":"CIPHERLOC Corp","issuer_ticker":"CLOK","issuer_name_source":null,"issuer_url":"/issuer/0001022505","owner_cik":null,"owner_name":"MANCHESTER MANAGEMENT CO LLC; BESSER JAMES E; Manchester Explorer, L.P.; MANCHESTER MANAGEMENT PR, LLC","owner_display_name":"MANCHESTER MANAGEMENT CO LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90000.0,"shares_display":"90,000","price_per_share":0.54,"price_display":"0.54","price_state":"stated","total_value":48600.0,"total_display":"48,600.00","total_whole":"48,600","shares_owned_after":4250400.0,"shares_owned_after_display":"4,250,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-26","filed_date":"2019-09-27","scope":"insider"},{"id":7858816,"accession":"0000919574-19-006090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-19-006090","line_url":"/filing/0000919574-19-006090#line-1","is_derivative":false,"issuer_cik":"0001022505","issuer_name":"CIPHERLOC Corp","issuer_ticker":"CLOK","issuer_name_source":null,"issuer_url":"/issuer/0001022505","owner_cik":null,"owner_name":"MANCHESTER MANAGEMENT CO LLC; BESSER JAMES E; Manchester Explorer, L.P.; MANCHESTER MANAGEMENT PR, LLC","owner_display_name":"MANCHESTER MANAGEMENT CO LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.51,"price_display":"0.51","price_state":"stated","total_value":5100.0,"total_display":"5,100.00","total_whole":"5,100","shares_owned_after":4160400.0,"shares_owned_after_display":"4,160,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-25","filed_date":"2019-09-27","scope":"insider"},{"id":8508050,"accession":"0000919574-19-003109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-19-003109","line_url":"/filing/0000919574-19-003109#line-1","is_derivative":false,"issuer_cik":"0001512127","issuer_name":"Medifirst Solutions, Inc.","issuer_ticker":"MFST","issuer_name_source":null,"issuer_url":"/issuer/0001512127","owner_cik":"0001512127","owner_name":"BESSER JAMES E","owner_display_name":"BESSER JAMES E","owner_url":"/insider/0001512127","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":96612.0,"shares_display":"96,612","price_per_share":0.07,"price_display":"0.07","price_state":"stated","total_value":6762.84,"total_display":"6,762.84","total_whole":"6,763","shares_owned_after":696612.0,"shares_owned_after_display":"696,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-01","filed_date":"2019-05-02","scope":"insider"},{"id":8115283,"accession":"0000919574-19-000042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-19-000042","line_url":"/filing/0000919574-19-000042#line-2","is_derivative":false,"issuer_cik":"0001022505","issuer_name":"CIPHERLOC Corp","issuer_ticker":"CLOK","issuer_name_source":null,"issuer_url":"/issuer/0001022505","owner_cik":null,"owner_name":"MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.; MANCHESTER MANAGEMENT CO LLC; BESSER JAMES E","owner_display_name":"MANCHESTER MANAGEMENT PR, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31145.0,"shares_display":"31,145","price_per_share":1.6929,"price_display":"1.69","price_state":"stated","total_value":52725.3705,"total_display":"52,725.37","total_whole":"52,725","shares_owned_after":3724300.0,"shares_owned_after_display":"3,724,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-03","scope":"insider"},{"id":8115282,"accession":"0000919574-19-000042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-19-000042","line_url":"/filing/0000919574-19-000042#line-1","is_derivative":false,"issuer_cik":"0001022505","issuer_name":"CIPHERLOC Corp","issuer_ticker":"CLOK","issuer_name_source":null,"issuer_url":"/issuer/0001022505","owner_cik":null,"owner_name":"MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.; MANCHESTER MANAGEMENT CO LLC; BESSER JAMES E","owner_display_name":"MANCHESTER MANAGEMENT PR, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":62655.0,"shares_display":"62,655","price_per_share":1.608,"price_display":"1.61","price_state":"stated","total_value":100749.24,"total_display":"100,749.24","total_whole":"100,749","shares_owned_after":3693155.0,"shares_owned_after_display":"3,693,155","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-31","filed_date":"2019-01-03","scope":"insider"},{"id":9208438,"accession":"0000919574-21-006529","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-21-006529","line_url":"/filing/0000919574-21-006529","is_derivative":false,"issuer_cik":"0001074871","issuer_name":"Modular Medical, Inc.","issuer_ticker":"MODD","issuer_name_source":null,"issuer_url":"/issuer/0001074871","owner_cik":null,"owner_name":"BESSER JAMES E; FRANK MORGAN C.; MANCHESTER MANAGEMENT CO LLC; MANCHESTER MANAGEMENT PR, LLC; Manchester Explorer, L.P.","owner_display_name":"BESSER JAMES E","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":720000.0,"shares_display":"720,000","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":1620000.0,"total_display":"1,620,000.00","total_whole":"1,620,000","shares_owned_after":917576.0,"shares_owned_after_display":"917,576","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-20","filed_date":"2021-10-29","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":"2018-11-20|9208436","ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001417663","name":"SANUWAVE Health, Inc.","url":"/issuer/0001417663","role":"Other","n_filings":4,"first_seen":"2024-10-23","last_seen":"2025-12-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001074871","name":"Modular Medical, Inc.","url":"/issuer/0001074871","role":"Officer (Chief Executive Officer), Ten percent owner, Other","n_filings":12,"first_seen":"2017-08-01","last_seen":"2025-03-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001533743","name":"Processa Pharmaceuticals, Inc.","url":"/issuer/0001533743","role":"Ten percent owner, Other","n_filings":5,"first_seen":"2020-10-13","last_seen":"2021-05-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001467761","name":"Zoom Telephonics, Inc.","url":"/issuer/0001467761","role":"Ten percent owner","n_filings":1,"first_seen":"2020-08-05","last_seen":"2020-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001022505","name":"CIPHERLOC Corp","url":"/issuer/0001022505","role":"Ten percent owner","n_filings":5,"first_seen":"2018-10-30","last_seen":"2019-10-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001522704","name":"Medifirst Solutions, Inc.","url":"/issuer/0001522704","role":"Ten percent owner","n_filings":1,"first_seen":"2019-05-02","last_seen":"2019-05-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001211583","name":"FENNEC PHARMACEUTICALS INC.","url":"/issuer/0001211583","role":"Ten percent owner","n_filings":8,"first_seen":"2018-03-29","last_seen":"2018-03-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001512127","retrieved_at":"2026-08-22T17:42:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}